CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial

Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas in the journal Nature Cancer.

Read more: https://blogs.bcm.edu/2024/05/21/from-the-labs-car-t-cell-therapy-targeting-her2-antigen-shows-promise-against-advanced-sarcoma-in-phase-i-trial/